A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

Clinical trial NCT04024761 · RECRUITING

Trial details

NCT number: NCT04024761
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Myeloproliferative Neoplasm Juvenile Myelomonocytic Leukemia

Start date: 2019-08-31
Primary completion: 2026-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.